Title |
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials |
|---|---|
Involved |
Joseph Kauer (Verfasser)
Emma P. Freundt (Verfasser) Anita Schmitt (Verfasser) Niels Weinhold (Verfasser)
Elias K. Mai (Verfasser)
Carsten Müller-Tidow (Verfasser) Hartmut Goldschmidt (Verfasser) Marc-Steffen Raab (Verfasser) Katharina Kriegsmann (Verfasser) Sandra Sauer (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
BMC cancer 23, 1, 21.11.2023, date:12.2023, Seite 1-11 |
Published |
2023 |
Language |
|
Country |
|
Topic |
|
Subject |
Cancer Biology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2024021210202009898582 (URN) |
Record ID |
1319004873 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: